Epitel

Epitel, founded in 2016, is a private medical device and digital health company developing a novel, wireless EEG monitoring system called REMI. Its platform combines disposable, wearable sensors with cloud-based data transmission and an AI tool (REMI Vigilenz) for event detection, aiming to provide rapid, accurate, and patient-friendly neurological monitoring. The company targets the significant unmet need for accessible, long-term EEG monitoring in both hospital and home environments to improve the diagnosis and management of seizure disorders. Epitel's system is designed to be reimbursable and integrates with existing clinical EEG review software.

Wireless, wearable EEG sensor system with cloud-based data transmission and AI-powered event detection software (REMI Vigilenz). Utilizes single-use, disposable sensors for up to 30-day monitoring.

Epitel competes in the ambulatory EEG and remote neurological monitoring market. Key competitors include established medical device companies with EEG product lines (e.g., Natus, Cadwell) and newer startups developing wearable EEG headsets. Epitel's differentiation lies in its truly wireless, disposable sensor design and its dedicated AI analytics platform for seizure detection.